Presentation on CES to the Food and Drug Administration in the US

BrainWhile Cranial Electro Stimulation devices are licensed in the US, they are only available by prescription. When dealing with CES technology since the 1980s, the Food and Drug Administration (FDA) has shown a reluctance to recognize the large body of research that has consistently been presented.

A presentation titled “Cranial Electrotherapy Stimulation Presentation to FDA Neurology Panel, February 2012” sums up the considerable body of CES research.